These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 34155922

  • 1. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
    Chen L, Tang K, Wang S, Chen D, Ding K.
    Cancer Control; 2021; 28():10732748211026668. PubMed ID: 34155922
    [Abstract] [Full Text] [Related]

  • 2. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y, Zheng Z, Xu R, Zhang H, Yin J, Liu X, Zhang J, Chen G, Zhang Z.
    Medicine (Baltimore); 2024 Mar 01; 103(9):e37289. PubMed ID: 38428860
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb 01; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 4. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Tu RH.
    Medicine (Baltimore); 2016 May 01; 95(21):e3473. PubMed ID: 27227913
    [Abstract] [Full Text] [Related]

  • 5. Explored Risk Factors for Lymph Node Metastasis with Siewert II/III Adenocarcinoma of the Gastroesophageal Junction.
    Zheng Z, Yin J, Wu HW, Li J, Cai J, Qin SQ, Zhang J, Yao HW, Li JS, Zhang ZT.
    Anticancer Res; 2017 Aug 01; 37(8):4605-4610. PubMed ID: 28739759
    [Abstract] [Full Text] [Related]

  • 6. Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.
    Chen K, Deng X, Yang Z, Yu D, Zhang X, Li W, Xie D, He Z, Cheng D.
    Expert Rev Gastroenterol Hepatol; 2020 Jun 01; 14(6):491-497. PubMed ID: 32324423
    [Abstract] [Full Text] [Related]

  • 7. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB, Lin MQ, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM.
    Eur J Surg Oncol; 2017 Dec 01; 43(12):2333-2340. PubMed ID: 28928013
    [Abstract] [Full Text] [Related]

  • 8. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H, Ooi M, Yu Z, Wang Q, Li Z, Lu Q, Wu Y.
    J Gastrointest Surg; 2019 Feb 01; 23(2):256-263. PubMed ID: 30334176
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL, Zhao LY, Zhang WH, Liu K, Pang HY, Chen XL, Chen XZ, Yang K, Hu JK.
    Langenbecks Arch Surg; 2022 May 01; 407(3):985-998. PubMed ID: 34792614
    [Abstract] [Full Text] [Related]

  • 10. Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction.
    Xu J, Cao J, Wang L, Wang Z, Wang Y, Wu Y, Lv W, Hu J.
    Sci Rep; 2017 Aug 31; 7(1):10123. PubMed ID: 28860457
    [Abstract] [Full Text] [Related]

  • 11. Risk factors and clinical significance of lower perigastric lymph node metastases in Siewert type II and III esophagogastric junction adenocarcinoma: a retrospective cohort study.
    Qi X, Liu M, Xu K, Tan F, Gao P, Yao Z, Zhang N, Yang H, Zhang C, Xing J, Cui M, Su X.
    Surg Endosc; 2024 Jul 31; 38(7):3828-3837. PubMed ID: 38822144
    [Abstract] [Full Text] [Related]

  • 12. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL.
    Ann Thorac Surg; 2019 Sep 31; 108(3):845-851. PubMed ID: 31102632
    [Abstract] [Full Text] [Related]

  • 13. Population-based analysis on predictors for lymph node metastasis in T1 colon cancer.
    Xu X, Zhang C, Ni X, Wu J, Pan C, Wang S, Yu J.
    Surg Endosc; 2020 Sep 31; 34(9):4030-4040. PubMed ID: 31620912
    [Abstract] [Full Text] [Related]

  • 14. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y, Liu D, Zeng D, Chen C.
    J Gastrointest Cancer; 2021 Sep 31; 52(3):983-992. PubMed ID: 32954465
    [Abstract] [Full Text] [Related]

  • 15. Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis.
    Brunner W, Widmann B, Marti L, Tarantino I, Schmied BM, Warschkow R.
    Surg Endosc; 2016 Oct 31; 30(10):4405-15. PubMed ID: 26895892
    [Abstract] [Full Text] [Related]

  • 16. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y, Wang Q, Wang J, Qiao XY, Zhang J, Lin YC, Li Y, Fan LQ, Yang PG, Zhao Q.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb 25; 24(2):128-137. PubMed ID: 33508918
    [Abstract] [Full Text] [Related]

  • 17. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 19. The development and validation of automated machine learning models for predicting lymph node metastasis in Siewert type II T1 adenocarcinoma of the esophagogastric junction.
    Lu C, Liu L, Yin M, Lin J, Zhu S, Gao J, Qu S, Xu G, Liu L, Zhu J, Xu C.
    Front Med (Lausanne); 2024 Feb 25; 11():1266278. PubMed ID: 38633305
    [Abstract] [Full Text] [Related]

  • 20. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
    Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ.
    Ann Thorac Surg; 2015 Jun 25; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.